nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Biperiden—ABCB1—adrenal gland cancer	0.00856	1	CrCbGaD
Trihexyphenidyl—CHRM3—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00817	0.00824	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00805	0.00812	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00791	0.00798	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00771	0.00777	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00757	0.00764	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00756	0.00762	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00733	0.00739	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00731	0.00737	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00724	0.0073	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00717	0.00724	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0069	0.00696	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00688	0.00694	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00687	0.00693	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00681	0.00687	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00677	0.00683	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00629	0.00634	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00627	0.00632	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00621	0.00626	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00613	0.00618	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00598	0.00603	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00587	0.00592	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00578	0.00583	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00562	0.00567	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00554	0.00558	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—TSHR—adrenal gland cancer	0.00546	0.00551	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00543	0.00547	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00541	0.00546	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00536	0.0054	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00533	0.00538	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00532	0.00536	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00526	0.00531	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00525	0.0053	CbGpPWpGaD
Trihexyphenidyl—CHRM4—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00525	0.00529	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—TSHR—adrenal gland cancer	0.00523	0.00528	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00509	0.00514	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00508	0.00512	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00503	0.00507	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00503	0.00507	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00502	0.00507	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00484	0.00488	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00482	0.00486	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00481	0.00485	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00477	0.00482	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00413	0.00417	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00412	0.00415	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00408	0.00411	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0039	0.00393	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00389	0.00392	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00385	0.00388	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00368	0.00372	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00367	0.0037	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00364	0.00367	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00354	0.00357	CbGpPWpGaD
Trihexyphenidyl—CHRM4—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00353	0.00356	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00353	0.00356	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00349	0.00352	CbGpPWpGaD
Trihexyphenidyl—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00349	0.00352	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00346	0.00349	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00339	0.00342	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00338	0.00341	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00334	0.00337	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00332	0.00335	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—GNAS—adrenal gland cancer	0.00318	0.0032	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00315	0.00317	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—GNRHR—adrenal gland cancer	0.0031	0.00313	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00309	0.00311	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00304	0.00307	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00301	0.00304	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00297	0.003	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00296	0.00298	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00288	0.00291	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00288	0.0029	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00281	0.00283	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—TSHR—adrenal gland cancer	0.0028	0.00283	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00276	0.00278	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00275	0.00278	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.00273	0.00275	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00271	0.00273	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00269	0.00271	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00268	0.00271	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0026	0.00262	CbGpPWpGaD
Trihexyphenidyl—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00235	0.00237	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00234	0.00236	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00233	0.00235	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00233	0.00235	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00231	0.00233	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00214	0.00216	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—POMC—adrenal gland cancer	0.00214	0.00216	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00214	0.00215	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00212	0.00214	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00211	0.00213	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00211	0.00213	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00209	0.00211	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00209	0.00211	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00208	0.0021	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00208	0.0021	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00207	0.00209	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00206	0.00208	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00205	0.00207	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00205	0.00207	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—POMC—adrenal gland cancer	0.00205	0.00207	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00201	0.00203	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00194	0.00196	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00194	0.00196	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00194	0.00195	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00193	0.00195	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00193	0.00194	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00192	0.00194	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00191	0.00193	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00189	0.00191	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00189	0.00191	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00189	0.0019	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00188	0.0019	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00188	0.0019	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00187	0.00189	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00187	0.00188	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—GNRH1—adrenal gland cancer	0.00186	0.00187	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00183	0.00184	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00182	0.00184	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0018	0.00182	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.0018	0.00182	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0018	0.00181	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00178	0.00179	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.00176	0.00177	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.00176	0.00177	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00172	0.00173	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CDC42—adrenal gland cancer	0.00171	0.00172	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—SPRY2—adrenal gland cancer	0.0017	0.00171	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TSHR—adrenal gland cancer	0.00166	0.00167	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CDC42—adrenal gland cancer	0.00163	0.00165	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—GNAS—adrenal gland cancer	0.00163	0.00164	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00163	0.00164	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TSHR—adrenal gland cancer	0.00159	0.0016	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—GNAS—adrenal gland cancer	0.00156	0.00158	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MEN1—adrenal gland cancer	0.00156	0.00157	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MEN1—adrenal gland cancer	0.00149	0.0015	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00145	0.00146	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.00144	0.00146	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00144	0.00145	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.00144	0.00145	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.00142	0.00144	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00136	0.00137	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00135	0.00136	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00134	0.00135	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—MED12—adrenal gland cancer	0.00131	0.00132	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.00128	0.00129	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00127	0.00128	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00126	0.00127	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00125	0.00126	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00125	0.00126	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00125	0.00126	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00124	0.00125	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00121	0.00122	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—POMC—adrenal gland cancer	0.00121	0.00122	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00121	0.00122	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0012	0.00121	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PRKACA—adrenal gland cancer	0.00119	0.0012	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—POMC—adrenal gland cancer	0.00116	0.00117	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00115	0.00116	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.00115	0.00116	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00115	0.00116	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.00114	0.00115	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PRKACA—adrenal gland cancer	0.00114	0.00115	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00114	0.00115	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00113	0.00114	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.00112	0.00113	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.00111	0.00112	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.0011	0.00111	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.0011	0.00111	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—POMC—adrenal gland cancer	0.0011	0.00111	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.0011	0.00111	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—POMC—adrenal gland cancer	0.00105	0.00106	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.00105	0.00106	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.00105	0.00106	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.00104	0.00105	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CDC42—adrenal gland cancer	0.00101	0.00102	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IGF2—adrenal gland cancer	0.000972	0.00098	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CDC42—adrenal gland cancer	0.000965	0.000974	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—GNAS—adrenal gland cancer	0.000963	0.000972	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.000955	0.000964	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000939	0.000948	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IGF2—adrenal gland cancer	0.000931	0.000939	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—GNAS—adrenal gland cancer	0.000922	0.00093	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IGF1R—adrenal gland cancer	0.0009	0.000907	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000815	0.000822	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000813	0.00082	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TERT—adrenal gland cancer	0.000809	0.000816	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000805	0.000812	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000801	0.000808	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000799	0.000806	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000791	0.000798	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	0.000774	0.000781	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.000774	0.000781	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.00076	0.000766	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.00074	0.000747	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000738	0.000744	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000731	0.000737	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	0.000704	0.00071	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.00068	0.000686	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000678	0.000683	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	0.000674	0.00068	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000671	0.000677	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000655	0.000661	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000653	0.000659	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.00065	0.000655	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	0.000649	0.000654	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000647	0.000653	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000647	0.000652	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000641	0.000647	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	0.00064	0.000646	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000633	0.000639	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000631	0.000637	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000625	0.000631	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	0.000621	0.000626	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000621	0.000626	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	0.000613	0.000619	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000594	0.0006	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000545	0.00055	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000544	0.000548	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000538	0.000543	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000521	0.000526	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000474	0.000478	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.000473	0.000477	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000468	0.000472	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000463	0.000467	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000443	0.000447	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000437	0.000441	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000436	0.00044	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000432	0.000436	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000432	0.000435	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.00043	0.000434	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000426	0.00043	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000419	0.000422	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000417	0.000421	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000416	0.000419	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000413	0.000417	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	0.000367	0.00037	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	0.000351	0.000354	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000312	0.000315	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000311	0.000314	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000308	0.000311	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	0.000308	0.000311	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	0.000295	0.000297	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000247	0.000249	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000246	0.000249	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000244	0.000246	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000208	0.000209	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000207	0.000209	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000205	0.000207	CbGpPWpGaD
